Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$24,577
in 1 filing

Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PAGANELLI JOHN A −$25K Director sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-07 FROST PHILLIP MD ET AL CEO & Chairman Purchase +9,100 $1.85 $17K 200,474,251
2023-08-07 FROST PHILLIP MD ET AL CEO & Chairman Purchase +160,243 $1.85 $296K 200,634,494
2023-08-07 FROST PHILLIP MD ET AL CEO & Chairman Purchase +21,432 $1.86 $40K 200,655,926
2023-08-07 FROST PHILLIP MD ET AL CEO & Chairman Purchase +25,768 $1.86 $48K 200,681,694
2023-06-22 Yu Alice Lin-Tsing Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-06-22 PFENNIGER RICHARD C JR Director Grant or award · Stock Option (Right to Buy) +60,000 60,000
2023-06-22 PAGANELLI JOHN A Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-06-22 MEDEL ROGER MD Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-06-22 Lachman Prem A Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-06-22 KRASNO RICHARD M Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-06-22 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-05-18 FROST PHILLIP MD ET AL CEO & Chairman Grant or award · Stock Option (Right to Buy) +800,000 800,000
2023-05-18 HSIAO JANE PH D Vice Chairman & CTO Grant or award · Stock Option (Right to Buy) +800,000 800,000
2023-05-18 Zerhouni Elias A. Vice Chairman and President Grant or award · Stock Option (Right to Buy) +800,000 800,000
2023-05-18 Rubin Steven D Executive VP-Administration Grant or award · Stock Option (Right to Buy) +700,000 700,000
2023-05-18 Logal Adam Sr. Vice President, CFO Grant or award · Stock Option (Right to Buy) +700,000 700,000
2023-05-18 Nabel Gary J. Chief Innovation Officer Grant or award · Stock Option (Right to Buy) +700,000 700,000
2023-05-05 Nabel Gary J. Chief Innovation Officer Purchase +19,285 $1.78 $34K 94,756
2023-05-05 Nabel Gary J. Chief Innovation Officer Purchase +3,185 $1.79 $6K 97,941
2023-05-05 Nabel Gary J. Chief Innovation Officer Purchase +27,777 $1.80 $50K 125,718

Page 10 of 33 · 653 trades